ID WEEK in SAN DIEGO

October 6, 2017

The Profounda team had a booth at this years ID Week convention.  Thanks to those that stopped by to learn more about Impavido

Please reload

Featured Posts

CDC Video showing N.Fowleri

July 21, 2017

1/4
Please reload

Recent Posts

October 6, 2017

Please reload

Archive
Please reload

Search By Tags
Please reload

Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

 Impavido® (miltefosine) is an FDA-approved treatment for cutaneous,  mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO